NASDAQ$VIVS
Oraganovo Holdings Inc · Q2 2025 earnings
Q2 2025 earnings · · Investor relations
Briefing
VIVS Q2 2025 — $50.0M revenue, 11.30 EPS
Operating results for any interim period are not necessarily indicative of the operating results for any other interim period or the Company’s full fiscal year ending March 31, 2025 (see “Note 1. Oraganovo Holdings Inc reported Q2 2025 results. Diluted EPS came in at $11.30. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $50.0M.
- Diluted EPS: $11.30.
- Filed on Form 10-Q (accession 0000950170-24-124044).
Headline financials
Revenue & EPS history
Organovo · Revenue · Quarterly
$30K
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2025
-0.4%
Avg return
Earnings day
+4.7%
Avg return
5 days after
+19.6%
Avg return
30 days after
46%
25 / 54 earnings
Positive
+15.3%
Q3 2013
Best reaction
-24.9%
Q4 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +0.0% | +4.2% | -6.3% | |
| Q1 2026 | -0.5% | +3.2% | +5.9% | |
| Q4 2025 | +0.0% | +2.2% | -18.3% | |
| Q3 2025 | +0.5% | +234.2% | -31.1% | |
| Q2 2025 | -7.2% | -16.3% | +7.0% | |
| Q1 2025 | -1.3% | +0.0% | +0.0% | |
| Q4 2024 | -1.8% | +2.0% | -22.4% | |
| Q3 2024 | -7.2% | +4.1% | +5.2% | |
| Q2 2024 | -22.4% | -14.9% | -36.2% | |
| Q1 2024 | -0.6% | -4.4% | -30.2% | |
| Q4 2023 | -4.5% | -0.6% | -11.2% | |
| Q3 2023 | +6.7% | +12.4% | -5.7% | |
| Q2 2023 | +7.3% | +8.6% | +12.6% | |
| Q4 2022 | -5.3% | -3.3% | +48.3% | |
| Q3 2022 | +10.5% | +4.7% | +40.4% | |
| Q2 2022 | +1.7% | -5.8% | -18.0% | |
| Q1 2022 | -1.5% | -0.9% | -0.6% | |
| Q4 2021 | +0.7% | +0.9% | +970.6% | |
| Q3 2021 | +13.7% | +29.9% | -24.0% | |
| Q2 2021 | -0.5% | -4.1% | -15.2% | |
| Q1 2021 | +5.3% | +0.0% | -50.0% | |
| Q4 2020 | +13.2% | +15.6% | -12.5% | |
| Q3 2020 | +6.2% | -6.1% | -24.2% | |
| Q2 2020 | +3.0% | +2.6% | +28.9% | |
| Q1 2020 | -4.4% | -3.6% | -7.1% | |
| Q4 2019 | -1.5% | -16.4% | -14.5% | |
| Q3 2019 | +2.0% | +4.1% | +5.1% | |
| Q2 2019 | +0.9% | -0.9% | -8.8% | |
| Q1 2019 | -13.1% | -13.8% | -4.6% | |
| Q4 2018 | -24.9% | -26.9% | -27.5% | |
| Q3 2018 | -10.2% | -20.4% | -13.9% | |
| Q2 2018 | +4.8% | -6.8% | -5.4% | |
| Q1 2018 | -1.4% | +3.8% | +3.3% | |
| Q4 2017 | -5.2% | -6.3% | -5.2% | |
| Q3 2017 | -13.3% | -19.0% | -20.9% | |
| Q2 2017 | +8.1% | +9.7% | +14.0% | |
| Q1 2017 | +3.4% | +4.8% | -12.0% | |
| Q4 2016 | +3.3% | +1.0% | +29.3% | |
| Q3 2016 | -8.6% | — | — | |
| Q2 2016 | -3.3% | — | — | |
| Q1 2016 | -9.6% | — | — | |
| Q4 2015 | +5.8% | — | — | |
| Q3 2015 | -1.5% | — | — | |
| Q2 2015 | -1.3% | — | — | |
| Q1 2015 | +2.5% | — | — | |
| Q4 2014 | -5.6% | — | — | |
| Q3 2014 | +8.7% | — | — | |
| Q2 2014 | +13.0% | — | — | |
| Q3 2013 | +15.3% | — | — | |
| Q1 2013 | +8.0% | — | — | |
| Q4 2012 | +0.0% | — | — | |
| Q3 2012 | -13.8% | — | — | |
| Q1 2012 | +2.0% | — | — | |
| Q4 2011 | +1.0% | — | — | |
| Q3 2011 | — | — | — | |
| Q1 2011 | — | — | — | |
| Q4 2010 | — | — | — | |
| Q3 2010 | — | — | — | |
| Q2 2010 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro